ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 170 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,159 | -76.1% | 82,700 | -62.5% | 0.00% | -66.7% |
| Q2 2023 | $1,094,926 | +51.0% | 220,307 | +353.5% | 0.00% | +50.0% |
| Q4 2021 | $725,000 | -46.3% | 48,576 | -7.6% | 0.00% | -60.0% |
| Q3 2021 | $1,351,000 | -29.4% | 52,572 | -3.0% | 0.01% | -37.5% |
| Q1 2021 | $1,913,000 | -26.8% | 54,202 | -47.7% | 0.01% | -27.3% |
| Q4 2020 | $2,615,000 | -42.9% | 103,606 | -14.6% | 0.01% | -38.9% |
| Q3 2020 | $4,577,000 | -6.7% | 121,382 | +6.0% | 0.02% | -28.0% |
| Q2 2020 | $4,905,000 | +79.6% | 114,547 | -18.5% | 0.02% | +38.9% |
| Q1 2020 | $2,731,000 | +107.1% | 140,489 | +176.7% | 0.02% | +350.0% |
| Q4 2019 | $1,319,000 | +223.3% | 50,767 | +234.4% | 0.00% | +300.0% |
| Q2 2019 | $408,000 | -58.2% | 15,181 | -55.1% | 0.00% | -75.0% |
| Q1 2019 | $977,000 | – | 33,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |